To view or add a comment, sign in Novartis has entered into an exclusive global #licensing and #collaboration #agreement with SciNeuro Pharmaceuticals to develop and commercialize novel therapies for #Alzheimers disease, in a deal valued at up to USD 1.7 billion
Po podaniu BPC-157 obserwowano szybkie uruchomienie krenia obocznego, midzy innymi przez ttnic trzustkowo-dwunastnicz doln i ttnic krezkow doln
PlexusDx is also cash-pay across all six Weight Management Protocols
Congenpharma with EMPHASES Empowering the Industry with Peptide Synthesis Platform Congen pharma focuses on the R&D and production of peptide and small molecule drugs, establishing the EMPHASES New liquid-phase peptide synthesis technology platform, using liquid-phase carriers to replace traditional solid-phase resins, improves reaction speed, shortens reaction time, and improves synthesis efficiency
Prepare for the mental and recovery needs by building support, taking time off for healing, and collaborating to manage expectations and follow aftercare steps with your care team